Global Business Innovation Programme: Advanced Therapies Sweden

Delivered by Innovate UK, the Global Business Innovation Programme consists of a 5-day tailored visit to Sweden with the opportunity to meet and collaborate with Swedish stakeholders and experts developing ATMP. It provides a unique experience for delegates to identify international partners for technology collaboration.

UK and Sweden

In 2022, the UK and Sweden signed a joint Memorandum of Understanding on health and life sciences, highlighting ATMP as a priority. This was followed by a Strategic Partnership Agreement, signed by UK and Swedish Prime Ministers in October 2023, which re-emphasised the importance of working together in science and innovation, including in this important sector. Therefore, opportunities for UK-Swedish ATMP collaboration and partnerships are significant and well supported at a strategic level. Read more GBIP Advanced Therapies Sweden brochure Innovate UK in partnership with Swedish organisations  and Enterprise Europe Network has arranged 1-2-1 business meetings on the following dates.

• 24th January 2024 Gothenburg
• 25th January 2024 Lund
• 29th January - 16th February 2024 online meetings

The sessions are open to Swedish companies and organisations with an interest in Advanced Therapies. UK companies attending: Astral Systems, Deliver Biosciences, Exogene, iLoF, Lentitek, MicrofluidX, ReproGo, Rinri Therapeutics, Stembond, Stratosvir, Unicorn Biotechnologies

Focus Technologies

• Manufacturing of cell therapies such as stem cell, natural killer (NK) cells, T cell, and other engineered cell therapies • Manufacturing of gene therapies using viral, and non-viral vectors • mRNA and viral vector-based vaccine manufacturing • Manufacturing of regenerative medicine • Development of personalised medicines